This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The funds will support clinical milestones along with AI-driven development across Juvenescence’s portfolio. The acquisition forms a key part of Juvenescence’s partnership with the Abu Dhabi global healthcare company M42, which was announced in April 2025.
June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The authorisation in the EU signifies a step forward in eye care for paediatric patients. Give your business an edge with our leading industry insights. Thank you for subscribing View all newsletters from across the GlobalData Media network.
June 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Enflonsia is administered to infants with the same dose regardless of their bodyweight. “We Give your business an edge with our leading industry insights. Thank you for subscribing View all newsletters from across the GlobalData Media network.
June 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The funds will be used to advance Mosanna’s nasal spray for obstructive sleep apnoea. Give your business an edge with our leading industry insights. Thank you for subscribing View all newsletters from across the GlobalData Media network.
Robert Barrie June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook US health secretary Robert F Kennedy Jr. wants to ensure the ensuing the US does not lag behind other countries in drug development. Give your business an edge with our leading industry insights. Login Registration is disabled.
June 9, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The partnership will expand treatment options for mental health in the US. .” Preparations are underway to introduce Exxua into the US market swiftly, aiming for pharmacy and patient access by late 2025. Login Registration is disabled.
June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The new facility in Hungary will create 100 local jobs. Give your business an edge with our leading industry insights. Thank you for subscribing View all newsletters from across the GlobalData Media network. Login Registration is disabled.
June 9, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook YOLT-101 will be a new treatment possibility for familial hypercholesterolemia. Give your business an edge with our leading industry insights. Thank you for subscribing View all newsletters from across the GlobalData Media network. Login Registration is disabled.
Alex Watt June 9, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The delays in market access in individual EU member states have been an obstacle to the industry. Credit: New Africa via Shutterstock. times more products than the overall European average. Give your business an edge with our leading industry insights.
Supporting sterile barrier packaging and supply chain resilience The Madison plant reinforces the TekniPlex Healthcare’s goal of assisting pharma and medical companies, which indirectly includes its downstream partners as well. June 12, 2025. Accessed June 18, 2025. May 6, 2025. Accessed June 18, 2025. Robinson S.
WASHINGTON — The White House is pitching an added benefit to Democrats’ recent drugpricing reform package: lower cancer death rates. Over 449,000 current Medicare enrollees with a prior cancer diagnosis would save an average of nearly $1,600 per year on prescription drugs because of the out-of-pocket cap.
… The White House is pitching an added benefit to the recent drug-pricing reform package: lower cancer death rates , STAT explains. A A new analysis by the Council of Economic Advisers focused on a provision that caps Medicare out-of-pocket costs for pharmacy drugs at $2,000 a year, starting in 2025.
Robert Barrie June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook NHS England estimates that nearly 2.5 Figures published in May 2025 by NHS England estimated there were nearly 2.5 million people in England live with ADHD. million people in England with ADHD. Login Registration is disabled.
Robert Barrie June 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Nasdaq’s trading boards will not parade Odyssey Therapeutics’ name for the time being. The autoimmune and inflammatory disease specialist was one in a wave of biotechs to reveal IPO ambitions in January 2025.
Published June 11, 2025 Amy Baxter Staff Reporter post share post print email license Win McNamee via Getty Images Listen to the article 5 min This audio is auto-generated. Currently, the program exempts orphan drugs from price negotiations if they only have one indication for rare disease.
Robert Barrie and Ross Law June 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The removal ACIP members marks the most significant upheaval to the current vaccine landscape under Trump’s administration. Go deeper with GlobalData Reports United States of America (USA) DrugPricing and Reimbursement Lands.
Leyla Hasanzadeh June 18, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Tech transfer for manufacturing purposes in India will be difficult if Trump imposes import duties on pharmaceuticals. The next few weeks of June and July 2025 will be pivotal for their trade relationship as negotiations enter advanced stages.
Deep Dive Library Events Press Releases Topics Sign up Search Sign up Search Pharma Biotech FDA Clinical Trials Deals DrugPricing Gene Therapy An article from Pharma’s wins and losses in the budget bill Key pharma reforms are up in the air as Republicans battle over their mammoth legislation that includes significant healthcare spending cuts.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content